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1   Occasion for the opinion 
 
The BfR has been asked to provide its expert opinion on the publication “Major pesticides are 
more toxic to human cells than their declared active principles” by the French task force led 
by Prof. Gilles-Eric Séralini.  
 
It is hypothesized that many pesticides (= plant protection products, PPP) are more toxic to 
humans and animals due to their mixed-in additives than their actual tested and approved 
active substances. This hypothesis is supported by cytotoxicity testing results derived from 
tests with nine active substances (including glyphosate) and one formulation of each active 
substance. 
 
2  Result  
 
The new publication by Mesnage et al. (2014) provides further indications that some PPP 
may have higher toxicity than the active substances contained therein. However, the publica-
tion does not provide any new information for the toxicological assessment of glyphosate and 
no general regulatory consequences can be derived from it. The publication’s aspects re-
garding the toxicological assessment of mixed-in additives in PPP are already incorporated 
in the BfR´s draft assessment report, which was prepared during the re-evaluation process of 
the active substance glyphosate in December 2013. The BfR report describes in detail that 
the toxicity of glyphosate-containing PPP is higher than the toxicity of glyphosate itself. The-
refore this new publication is of no relevance to the current re-evaluation process of gly-
phosate in the European Union. 
 
The used methods are suitable for cytotoxicity testing of active substances and their formula-
tions and the in vitro data seem plausible. Therefore the data are considered to be additional 
indications to the BfR draft re-evaluation report. However, the data are not sufficient for a 
comprehensive regulatory assessment of PPP. The data are also inadequately for the as-
sessment of the transferability of the results to intact organisms including humans.  
The publication by Mesnage et al. (2014) and the comments in the BfR´s draft assessment 
report highlighting the need for research in the area of combined toxicity to which the BfR will 
continue to contribute.  
 
3   Statement of reasons 
 
Assessing the cumulative toxicity of PPP for the purpose of determining the risk to human 
health is laid down in the relevant EU regulations and poses a great challenge for experimen-
tal and regulatory toxicology. Cumulative effects can, on the one hand, result from the inter-
action between the various active substances in different PPP and then from the interaction 
between active substances and mixed-in additives within the same PPP. The publication by 
Mesnage et al. (2014) refers to the latter case. Due to the large number of approved PPP it is 
not feasible to test all the theoretically possible combination effects through repeated expo-
sure as part of conventional animal experiments. For this reason, it is very important to de-
velop and validate suitable model systems which can be uesd as screening test battery prior 
to any animal experiments.  
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The French researchers led by by Prof. Séralini report in their publication (published in ad-
vance http://www.hindawi.com/journals/bmri/aip/179691/ but not available as print yet) on in 
vitro cytotoxicity experiments of nine active substances of PPP and one formulation for each 
active substance. As test systems three well characterized cell lines of human origin were 
used: HepG2 (liver), JEG-3 (placenta) and HEK293 (embryonic kidneys).  
These cell lines are also often used by the BfR to investigate combination effects of PPP in 
vitro by using the following methods: 
   
? The MTT test investigates the damage to cell organelles and hence, indirectly, to cel-
lular respiration on the basis of a measurement of succinate dehydrogenase activity 
in mitochondria following 24-hours exposure. 
 
? The measurement of adenylate kinase release as an indication of damage to mem-
branes (necrosis markers). 
 
? The determination of the apoptosis rate in “Caspase-Glo 3/7-Assay”.  
 
The methods are often used in cytotoxicity testing and it seems that there are correctly ap-
plied. At least for the MTT test experimental experiences are available at BfR.  
 
Using the same methods and the same cell lines, Mesnage and colleagues (Mesnage et al. 
2013) had already demonstrated increased toxicity of glyphosate-containing formulations and 
/ or adjuvants compared to the active substance glyphosate. Showing this, the findings of 
other groups were confirmed. The BfR have already taken into account these data in the 
German draft assessment report, which was prepared during the re-evaluation process of the 
active substance glyphosate in December 2013. For the current EU assessment of gly-
phosate the newly published data does not provide any new information. 
 
The in vitro experiments cover a wide range of concentrations. It is to be assumed that the 
actual concentration levels after exposure to the active substances or its formulations in hu-
man tissue and organs tend to be lower due to kinetics (distribution, excretion) than actual 
tested. Moreover, it is not to be expected that the organism is affected consistently over 24 
hours by the substances. These uncertainties can be removed by oral or dermal administra-
tion studies, where the concentration of the substances in liver and other organs were de-
termined. The obtained range of concentration can than be used in follow-on in vitro studies. 
For the BfR´s assessment of the testing results by Mesnage and colleagues, only limited 
data are available. The BfR collected by itself in 2012 such data for some active substances 
acting as fungicide. In consideration of the BfR test results and the results of Mesnage et al. 
(2014), BfR can conclude that the tested concentration is almost realistic for the liver after 
exposure to the active substances epoxiconazole and prochloraz.  
 
In eight of nine cases of the tests described by Mesnage et al. (2014), the tested active sub-
stances (fungicides: epoxiconazole, prochloraz, tebuconazole; herbicides: fluroxypyr as its 
methylheptyl ester, glyphosate; insecticides: acetamiprid, imidacloprid, and pirimicarb) were 
less toxic than their respective formulations. The herbicide isoproturon was poorly soluble 
like its formulation Matin, and therefore the results for both will not taken into account for the 
assessment. The major difference in toxicity between the active substance and the formula-
tion in almost all tests systems and types of cell lines was found between the active sub-
stance glyphosate and its formulation Roundup GT+ with an ethoxylated ether alkylamine as 
its declared adjuvant. However, the active substance glyphosate showed especially low cyto-
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toxicity in MTT tests compared to all other active substances. Nevertheless the difference 
was significant. 
 
For the other test methods listed above, the differences, notably for fungicides, were not as 
pronounced as in the MTT test. The results were also depended on the cell line. 
 
For one of the methods, the MTT test, the BfR has gained experimental experience with the 
three active substances epoxiconazole, prochloraz, and tebuconazole tested in the two of the 
cell cultures used by Mesnage et al. (2014), i.e. HepG2 (liver) and JEG-3 (placenta) cells. 
For epoxiconazole and prochloraz, cytotoxicity to placenta cells was in the same concentra-
tion range as described in the publication. In the case of prochloraz, this also applies to liver 
cells. Due to the different dosages chosen for epoxiconazole in liver cells a comparison be-
tween the tests of Mesnage et al. (2014) and BfR is not possible. 
Regarding the active substance tebuconazol BfR suspects a dilution error in the testing se-
ries due to the very high LC50 values and the fact, that tebuconazol already precipitates at 
the concentration used by Mesnage and colleagues. Therefore, the effective cytotoxicity of 
tebuconazole can not be confirmed and BfR is questioning the statement that the formulation 
Maronee is 1056 times more toxic than the active substance tebuconazole. 
 
In conclusion, the data for the MTT test are considered reproducible on the basis of the BfR’s 
own experience. The findings of the apoptosis testing are not robust at least for the formula-
tions because of using dosages in the range which is already cytotoxic. 
  
In order to be able to derive generally valid consequences for regulatory purposes it would 
be necessary to determine first which in vitro tests are most suitable to show higher toxicity 
of PPP formulations compared to the active substance. The methods and cell lines used by 
Mesnage et al. (2013, 2014) can be taken into consideration. However, given the current 
state of knowledge, they are certainly not sufficient. What is required, rather, is a screening 
test battery made up of suitable in vitro tests. On the basis of these results it is then possible 
to decide which PPP formulations show higher toxicity. This could subsequently lead to sys-
tematic further experiments with repeated administration. This procedure is the only way to 
avoid unnecessary animal experiments and to use scarce resources efficiently. To achieve 
this, collective efforts on the part of government authorities, academic research institutions, 
and the applicant industry are of high impact and indispensable. The BfR will make a contri-
bution to these efforts in the form of a workshop on the regulatory categorization of data 
which have been collected, by means of new bio-molecular methods, from cell cultures and 
animal tissue. The workshop is planned for the fourth quarter 2014. 
 
For far-reaching regulatory consequences, for example in relation to the recently amended 
data requirements for pesticides and their active substances, the current data basis is not 
sufficient. The new publication can be seen as a stimulus for further discussion.  
 
It is important to note, that there is strong evidence for the higher toxicity of glyphosate-
containing herbicides than for the active substance glyphosate due to mixed-in additives in 
the PPP (see BfR´s draft assessment report). The new publication by Mesnage et al. (2014) 
provides further indications that this also applies for some other PPP. However, it remains 
still an open question what relevance these in vitro findings in the commented publication 
have for the health assessment of PPP. 
 
Independently of this new publication, the BfR is planning to conduct further research into the 
combined toxicity of different active substances and the combination effects of active sub-
stances and mixed-in additives. A relevant draft for the project was presented to the Federal 
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Ministry of Food and Agriculture (BMEL) in December 2013. The need for more research in 
this specific area is of particular importance and is substantiated by the new publication of 
Mesnage (Mesnage et al. 2014). 
 
4   References 
 
Mesnage, R.; Defarge, N.; Spiroux de Vendômois, J. and Séralini, G.-E. (2014, in press): 
Major pesticides are more toxic to human cells than their declared active principles. 
http://www.hindawi.com/journals/bmri/aip/179691/ 
 
Mesnage, R.; Bemay, B. and Séralini, G.E. (2013): Ethoxylated adjuvants of glyphosate-
based herbicides are active principles of human cell toxicity. Toxicology, 313 (2-3), 122-128. 
(PMID:23000283) 
